1. Endocrinology-informed neuroimaging in eating disorders: GLP1, orexins, and psilocybin.
- Author
-
Steward T
- Subjects
- Humans, Neuroimaging, Orexins therapeutic use, Psilocybin therapeutic use, Glucagon-Like Peptide-1 Receptor agonists, Binge-Eating Disorder diagnostic imaging, Binge-Eating Disorder drug therapy, Feeding and Eating Disorders diagnostic imaging, Feeding and Eating Disorders drug therapy
- Abstract
The neurobiology of eating disorders [EDs; anorexia nervosa (AN), bulimia nervosa (BN), and binge eating disorder (BED)] remains poorly understood. Here, I describe how neuroimaging, accompanied by peripheral endocrine measures, can provide insights into the neurobiological drivers of eating disorders. Orexins/hypocretins, glucagon-like peptide-1 receptor (GLP1R) agonists, and psilocybin are highlighted as avenues for investigation., Competing Interests: Declaration of interests The author has no conflicts of interest to declare., (Copyright © 2023 Elsevier Ltd. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF